What 'trough symptoms' actually mean

The phrase 'trough symptoms' is doing a lot of work in injectable hormone communities. Here is what the kinetics support, what they don't, and how to think about late-week dips without over-interpreting them.

"Trough symptoms" is one of the most commonly used phrases in TRT and injectable hormone communities. It usually refers to subjectively-felt fatigue, low mood, low libido or general flatness in the last day or two before the next scheduled injection. The kinetics offer a partial explanation; the literature offers a more cautious one. This post tries to map the gap between the two.

This is educational background, not clinical advice. If you are experiencing symptoms you attribute to your protocol, the right place to take that conversation is to the clinician who prescribed it.

What the kinetics actually predict

On a once-weekly schedule of an 8-day-half-life ester, the modelled mg-remaining at the trough sits at roughly 55–60% of the peak — a meaningful oscillation in the chart, but only after several weeks of steady-state dosing. Whether that oscillation maps to a noticeable subjective change depends on:

The shape of the dose-response curve for the relevant physiological effect (often non-linear, with plateaus).
The lag between serum level and downstream physiological effect (hours to days for some androgen-dependent endpoints).
Whether the relevant feedback loops have fully adjusted to the new steady state.
Individual sensitivity to a given absolute level.

The chart shows the input side. The body's response is not a straight-line readout of the chart.

What the published literature says

Studies of perceived energy, mood and libido as a function of within-cycle testosterone level are surprisingly mixed. The 2008 Bhasin et al. work and subsequent reviews suggest that subjective effect is correlated with average exposure more reliably than with intra-cycle peak or trough. The Endocrine Society guidance recognises symptomatic variation across the injection cycle as a real phenomenon for some patients, and notes that more frequent dosing can address it — but stops short of attributing all late-cycle symptoms to the trough itself.

In other words: trough symptoms are recognised in clinical guidance, more frequent dosing is a recognised response, and individual variation is large enough that no single protocol fits every patient.

What else could be going on

Before reaching for "this must be the trough", here are the alternative explanations worth considering, all of which can produce a similar pattern:

Sleep. A bad few nights at the end of the week is the most common explanation for end-of-week fatigue, and is often misattributed to the injection cycle when it correlates with the weekly schedule purely by coincidence.
Recovery debt. People who train hard on a Monday-to-Friday cycle often feel flattest on Friday or Saturday regardless of any hormone protocol.
Alcohol and dietary variation. Weekly patterns of intake produce weekly patterns of symptoms.
Reverse expectation effect. Knowing that "the trough is coming" is a powerful framing that primes attention to fatigue at the expected time.
Active metabolite oscillation. For testosterone, estradiol and DHT levels oscillate alongside testosterone, and the perceived effect can be driven by one of those rather than the parent.
Unrelated stressors. Work, relationships, sleep and seasonal changes all produce symptom patterns that the injection schedule does not cause.
Co-administered medications. Schedule changes in any other prescription can mimic trough symptoms.

The discipline is to keep the chart's pattern as one hypothesis among several, not the default explanation.

How to test whether it's actually the trough

If you have a clinical conversation about whether trough symptoms are real for you, the cleanest test is to flatten the curve at the same average dose and see if the symptom pattern persists. That usually means moving from once-weekly to twice-weekly at half the per-injection dose, and observing for several weeks. If the late-week symptom resolves, the trough hypothesis is supported. If it does not, the symptom likely has another cause and chasing it through further frequency increases is unlikely to help.

This is a clinical experiment, and it belongs in a clinician's care. Do not use the DoseCurve chart as authorisation to change your protocol unilaterally.

What the model is good for here

The chart is useful for:

Showing the magnitude of the trough relative to the peak under your current schedule.
Demonstrating how much smoother an alternative cadence would be.
Anchoring a conversation with a prescriber in numbers rather than vibes.

The chart is not useful for:

Predicting whether you specifically will feel a trough.
Predicting how flat your curve needs to be for symptoms to resolve.
Substituting for a clinician's judgement on whether a cadence change is the right response.

A note on "I feel the trough on Friday"

This is one of the most common phrases on TRT forums. The kinetics frequently support it as a plausible hypothesis. They also frequently support sleep, training, and life as equally plausible co-causes. The right next step is usually:

Track sleep, training and mood independently for a few weeks.
Record the time-since-injection at each tracking point.
Bring the data to your prescriber.
Let them propose what to test next.

Skipping straight from "I feel low on Friday" to "I need to inject twice as often" is a leap the chart alone does not justify.